Asia’s “nascent capital market” needs a catalyst — but investors shouldn’t be deterred from investing in the region’s private ...

As most followers of the PIMCO Dynamic Income Strategy fund (PDX) know, the rapid-growth trajectory of the fund has been ...

Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...

SailPoint said on Tuesday it was targeting a valuation of up to $11.5 billion in its New York flotation, as the cybersecurity ...

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

SailPoint is targeting a valuation of up to US$11.5 billion ($18.4 billion) in its New York flotation, as the cyber security ...

Cryptocurrency exchange Bullish Global, whose backers include billionaire venture capitalist Peter Thiel, is weighing an initial public offering as soon as this year, according to a media report dated ...

Bernstein initiated coverage of Venture Global (NYSE:VG), a $51.9 billion market cap LNG company, with a Market Perform rating and set a price target of $20.00. The research firm sees a modest 2% ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...